Conjugated bilirubin reduces hepatitis E virus infectivity by modulating immunometabolic processes
Clicks: 1
ID: 317025
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #73 of 87 articles by views in journal of leukocyte biology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Despite the landmark discovery of the hepatitis E virus (HEV) four decades ago and its status as the leading cause of viral hepatitis worldwide, the infection remains overlooked in numerous countries. Currently, there are no approved treatments for hepatitis E or licensed vaccines available for global distribution. The clinical presentation of infection is influenced by the host's immune response and may also be affected by metabolic factors. We previously reported an immunomodulatory role for conjugated bilirubin (cBR) in hepatitis A virus infection, and antiviral effects of this metabolite have been proposed. However, the impact of cBR on HEV infectivity and the mechanisms underlying this effect have yet to be elucidated. By combining 1) ex vivo analysis of HEV-infected patients, 2) in vitro antigenic restimulation of peripheral blood mononuclear cells (PBMCs) cultured with different cBR doses, and 3) in vitro infection of permissive cell lines, we found that cBR concentrations of 2 mg/dL lowered viral titers and increased IFN-γ release in patients with acute infection. Furthermore, antigenic restimulation of PBMCs cultured with 2 mg/dL cBR promoted positive interactions between TNF-α and metabolic signaling proteins such as Akt and ERK. Moreover, cBR induced the overproduction of IFN-γ by CD8+ T cells from individuals with prior HEV exposure and decreased viral titers in both acute and chronic infection models at concentrations greater than or equal to 0.3 mg/dL. These findings demonstrate that during HEV infection, cBR plays a significant role in modulating the interaction between immune and metabolic components, ultimately influencing viral infectivity.
| Reference Key |
openalex_W7164348266
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Javier Orozco-Cordoba, Julio Y. Anaya-Covarrubias, Minerva D Santiago, Diego Zamora, Sonia Román, Arturo Panduro, Julio César Carrero, Nora A. Fierro |
| Journal | journal of leukocyte biology |
| Year | 2026 |
| DOI |
10.1093/jleuko/qiag078
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.